Trials / Conditions / Cancer of the Esophagus

Cancer of the Esophagus

14 registered clinical trials studyying Cancer of the Esophagus — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Active Not Recruiting	Radiation Dose Intensification With Accelerated Hypofractionated Intensity Modulated Radiation Therapy and Con NCT04046575	Washington University School of Medicine	Phase 1
Withdrawn	Feasibility and Safety of Using Nasal High Flow Oxygen Postoperatively to Reduce Respiratory Complications NCT04272268	University Hospitals of North Midlands NHS Trust	—
Completed	Nordic Gastric and Esophageal Tumor Study NCT05688761	Karolinska Institutet	—
Active Not Recruiting	Proton Beam Therapy in the Treatment of Esophageal Cancer NCT03482791	Washington University School of Medicine	N/A
Terminated	Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and Recur NCT03108885	Mayo Clinic	—
Completed	Pembrolizumab With Locally Delivered Radiation Therapy for the Treatment of Metastatic Esophageal Cancers NCT02642809	Washington University School of Medicine	Phase 1
Withdrawn	Study of Inspiratory Muscle Training for Patients Undergoing Esophageal Surgery NCT02843750	Mayo Clinic	N/A
Recruiting	Mayo Clinic Upper Digestive Disease Survey NCT02530983	Mayo Clinic	—
Completed	Timing of Resective Surgery After Neoadjuvant Chemoradiotherapy in Esophageal Cancer NCT02415101	Karolinska University Hospital	N/A
Completed	A Trial of ZD6474, Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiation Therapy Followed by Surgery NCT01183559	Fox Chase Cancer Center	Phase 1
Completed	Phase I/II Study of Panitumumab, Capecitabine and Oxaliplatin w EBRT for Esophageal Cancer NCT00578071	Brian Czito	Phase 1 / Phase 2
Unknown	TaxXel: Taxotere and Xeloda in Esophageal Cancer NCT00821912	Karolinska University Hospital	Phase 1 / Phase 2
Completed	Incidence and Patterns of Nausea/Vomiting With Combined Chemotherapy and Radiation NCT00716157	Thomas Jefferson University	—
Completed	Irinotecan and Taxotere With Radiotherapy as Preoperative Treatment in Resectable Esophageal Cancer NCT00318903	University of Alabama at Birmingham	Phase 2